m+Medelevator.RU
← Поиск публикаций
Women's health reports (New Rochelle, N.Y.) · 2025

Acceptance of the COVID-19 Vaccine Among Postpartum Women in Five Countries.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Lee Eun Young, Chien Li-Yin, Chang Yan-Shing, Hong Seo Ah, Coca Kelly Pereira

Аннотация

OBJECTIVES: This study identified factors associated with COVID-19 vaccine acceptance and willingness to receive the vaccine among postpartum women in the United Kingdom, Thailand, Taiwan, Brazil, and South Korea.

METHODS: An online cross-sectional survey was designed and conducted from July to November 2021. Data from 3,253 women who were up to 6 months postpartum in the United Kingdom, Thailand, Taiwan, Brazil, and South Korea were analyzed. Simple and multiple logistic regression analyses were performed.

RESULTS: Approximately 72% of women had received at least one dose of the vaccine with a range from 97.0% in Brazil to 25.2% in South Korea. Among five countries, positive attitudes and beliefs toward the COVID-19 vaccine were associated with COVID-19 vaccine acceptance (odds ratio [OR]: 1.41; 95% confidence interval [CI]: 1.35, 1.47). Higher education, paid employee status, and urban residence were associated with COVID-19 vaccine acceptance. The country-specific analysis results showed that attitudes and beliefs toward the COVID-19 vaccine were a strong predictors of COVID-19 vaccine acceptance and willingness to receive it among postpartum women.

CONCLUSION: Positive attitudes and beliefs toward the COVID-19 vaccine and better COVID-19-related knowledge, attitudes, and practices are important for acceptance of the vaccine in postpartum women. Therefore, there is a need for sufficient and clear communication on the novel vaccine's safety and efficacy to improve awareness and attitudes among postpartum women.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты